Can a Constipation Drug Protect Kidneys?

What if one of the most promising new ideas in chronic kidney disease came from a constipation drug? This video explores a surprising clinical trial that suggests a familiar gut medication may help slow kidney decline. You’ll learn what researchers in Japan found, why the gut-kidney axis matters, how spermidine and mitochondria may be involved, and why this result is exciting but still early. Topics covered: Chronic kidney disease and why it matters The gut-kidney axis Lubiprostone and the LUBI-CKD trial eGFR and kidney function decline Gut bacteria, spermidine, and mitochondria Why phase 3 trials matter If you enjoy evidence-based health explainers, like and subscribe for more. Sources: https://www.sciencedaily.com/releases/2026/05/260508024740.htm https://www.tohoku.ac.jp/en/press/clinical_trial_showing_lubiprostone_aids_kidney_function.html https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/what-is-chronic-kidney-disease https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis https://www.kidney.org/kidney-topics/estimated-glomerular-filtration-rate-egfr https://medlineplus.gov/druginfo/meds/a607034.html https://medlineplus.gov/spanish/druginfo/meds/a607034-es.html https://www.ncbi.nlm.nih.gov/books/n/livertox/Lubiprostone/ https://www.medlineplus.gov/ https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/kidney-disease/identify-manage-patients/evaluate-ckd https://en.wikipedia.org/wiki/Lubiprostone https://www.kidney.org/content/kidney-failure-risk-factor-estimated-glomerular-filtration-rate-egfr https://www.kidney.org/kidney-topics/health-equity-and-chronic-kidney-disease https://www.ovid.com/journals/sciad/abstract/10.1126/sciadv.adw3934~lubiprostone-in-chronic-kidney-disease-insights-into https://www.ncbi.nlm.nih.gov/medgen/981220 https://www.niddk.nih.gov/-/media/Files/Health-Information/Health-Professionals/Kidney-Disease/working-groups/Cleveland_Clinic_Development_of_an_EHR-based_CKD_Registry_508.pdf https://www.911globalmeds.com/info/1503-1-Lubiprostone-Amitiza-Medication-Patient-Information-In-English.pdf https://en.wikipedia.org/wiki/Chronic_kidney_disease https://externalcontent.atitesting.com/pme/resources/DITGastrointestinalLubiprostone.pdf https://www2.niddk.nih.gov/-/media/Files/Strategic-Plans/2024/NIDDK_RecentAdvances_2024-full.pdf https://www.niddk.nih.gov/-/media/Files/Strategic-Plans/Diabetes-in-America-3rd-Edition/DIA_Ch22.pdf 00:00 Hook 00:46 The Big Idea 01:50 What the Trial Found 03:08 Why It Might Work 03:44 The Bigger Scientific Context 04:38 Why Researchers Are Paying Attention 05:09 Important Limits and Cautions 05:46 Real-World Implications 07:10 Key Takeaways 08:08 Closing Question #KidneyDisease #CKD #GutHealth #MedicalResearch #Lubiprostone Generated by AutoVidSync.com